These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 19237403

  • 1. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [Abstract] [Full Text] [Related]

  • 2. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 3. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.
    J Cardiovasc Magn Reson; 2007 Jan; 9(5):749-58. PubMed ID: 17891611
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 5. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 6. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB.
    Clin Chim Acta; 2007 Feb 15; 376(1-2):168-73. PubMed ID: 17011538
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
    Conen D, Zeller A, Pfisterer M, Martina B.
    Am J Cardiol; 2006 Jan 15; 97(2):249-52. PubMed ID: 16442372
    [Abstract] [Full Text] [Related]

  • 8. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun 15; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Am J Cardiol; 2009 Jan 01; 103(1):22-8. PubMed ID: 19101224
    [Abstract] [Full Text] [Related]

  • 10. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M.
    Eur J Clin Invest; 2007 May 01; 37(5):350-6. PubMed ID: 17461980
    [Abstract] [Full Text] [Related]

  • 11. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 01; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 14. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG.
    Nephron Clin Pract; 2008 Sep 15; 110(2):c93-100. PubMed ID: 18815449
    [Abstract] [Full Text] [Related]

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec 15; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 16. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
    Ng LL, Pathik B, Loke IW, Squire IB, Davies JE.
    Am Heart J; 2006 Jul 15; 152(1):94-101. PubMed ID: 16824837
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
    Mark PB, Stewart GA, Gansevoort RT, Petrie CJ, McDonagh TA, Dargie HJ, Rodger RS, Jardine AG.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):402-10. PubMed ID: 16221702
    [Abstract] [Full Text] [Related]

  • 18. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456
    [Abstract] [Full Text] [Related]

  • 19. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.
    Am J Cardiol; 2006 Jul 01; 98(1):111-5. PubMed ID: 16784932
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S, Webb MC, Price CP, John RI, Abbas NA, Lamb EJ.
    Nephrol Dial Transplant; 2008 Nov 01; 23(11):3546-53. PubMed ID: 18562472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.